Quantifying brain iron deposition in patients with Parkinson's disease using quantitative susceptibility mapping, R2 and R2*

Andrews, 1999, Disorders of iron metabolism, N Engl J Med, 341, 1986, 10.1056/NEJM199912233412607 Sofic, 1988, Increased iron (III) and total iron content in post mortem substantia nigra of Parkinsonian brain, J Neural Transm, 74, 199, 10.1007/BF01244786 Dexter, 1987, Increased nigral iron content in postmortem Parkinsonian brain, Lancet, 2, 1219, 10.1016/S0140-6736(87)91361-4 Griffiths, 1999, Iron in the basal ganglia in Parkinson’s disease. An in vitro study using extended X ray absorption fine structure and cryo electron microscopy, Brain, 122, 667, 10.1093/brain/122.4.667 Sofic, 1991, Selective increase of iron in substantia nigra zona compacta of Parkinsonian brains, J Neurochem, 56, 978, 10.1111/j.1471-4159.1991.tb02017.x Kosta, 2006, MRI evaluation of the basal ganglia size and iron content in patients with Parkinson’s disease, J Neurol, 253, 26, 10.1007/s00415-005-0914-9 Ryvlin, 1995, Magnetic resonance imaging evidence of decreased putamenal iron content in idiopathic Parkinson’s disease, Arch Neurol, 52, 583, 10.1001/archneur.1995.00540300057013 Gorell, 1995, Increased iron-related MRI contrast in the substantia nigra in Parkinson’s disease, Neurology, 45, 1138, 10.1212/WNL.45.6.1138 Bartzokis, 1999, MRI evaluation of brain iron in earlier and later onset Parkinson’s disease and normal subjects, Magn Reson Imaging, 17, 213, 10.1016/S0730-725X(98)00155-6 Du, 2011, Combined R2* and diffusion tensor imaging changes in the substantia nigra in Parkinson’s disease, Mov Disord, 26, 1627, 10.1002/mds.23643 Peran, 2010, Magnetic resonance imaging markers of Parkinson’s disease nigrostriatal signature, Brain, 133, 3423, 10.1093/brain/awq212 Graham, 2000, Brain iron deposition in Parkinson’s disease imaged using the PRIME magnetic resonance sequence, Magn Reson Imaging, 2423 Baudrexel, 2010, Quantitative mapping of T1 and T2* discloses nigral and brainstem pathology in early Parkinson’s disease, Neuroimage, 51, 512, 10.1016/j.neuroimage.2010.03.005 Martin, 2008, Midbrain iron content in early Parkinson disease: a potential biomarker of disease status, Neurology, 70, 1411, 10.1212/01.wnl.0000286384.31050.b5 Mondino, 2002, Magnetic resonance relaxometry in Parkinson’s disease, Neurol Sci, 23, 87, 10.1007/s100720200083 Braffman, 1989, MR imaging of Parkinson disease with spin-echo and gradient-echo sequences, Am J Roentgenol, 152, 159, 10.2214/ajr.152.1.159 Groger, 2012, Does structural neuroimaging reveal a disturbance of iron metabolism in Parkinson’s disease? Implications from MRI and TCS studies, J Neural Transm, 119, 1523, 10.1007/s00702-012-0873-0 Kennan, 1994, Intravascular susceptibility contrast mechanisms in tissues, Magn Reson Med, 31, 9, 10.1002/mrm.1910310103 Liu, 2009, Calculation of susceptibility through multiple orientation sampling (COSMOS): a method for conditioning the inverse problem from measured magnetic field map to susceptibility source image in MRI, Magn Reson Med, 61, 196, 10.1002/mrm.21828 Langkammer, 2012, Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study, Neuroimage, 62, 1593, 10.1016/j.neuroimage.2012.05.049 Schweser, 2011, Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: an approach to in vivo brain iron metabolism?, Neuroimage, 54, 2789, 10.1016/j.neuroimage.2010.10.070 Wharton, 2010, Whole brain susceptibility mapping at high field: a comparison of multiple and single orientation methods, Neuroimage, 53, 515, 10.1016/j.neuroimage.2010.06.070 Tang, 2012, Improving susceptibility mapping using a threshold based K space image domain iterative reconstruction approach, Magn Reson Med, 69, 1396, 10.1002/mrm.24384 Zheng, 2013, Measuring iron in the brain using quantitative susceptibility mapping and X-ray fluorescence imaging, Neuroimage, 78, 68, 10.1016/j.neuroimage.2013.04.022 Langkammer, 2013, Quantitative susceptibility mapping in multiple sclerosis, Radiology, 267, 551, 10.1148/radiol.12120707 Liu, 2013, Improved subthalamic nucleus depiction with quantitative susceptibility mapping, Radiology, 269, 216, 10.1148/radiol.13121991 Dormont, 2004, Is the subthalamic nucleus hypointense on T2-weighted images? A correlation study using MR imaging and stereotactic atlas data, AJNR Am J Neuroradiol, 25, 1516 Lotfipour, 2012, High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson’s disease, J Magn Reson Imaging, 35, 48, 10.1002/jmri.22752 Burgetová, 2010, Magnetic resonance relaxometry in multiple sclerosis – T2 relaxation time measurement in central gray matter, Ces Slov Neurol, 73, 26 Feinberg, 1991, GRASE (gradient- and spin-echo) MR imaging: a new fast clinical imaging technique, Radiology, 181, 597, 10.1148/radiology.181.2.1924811 Bilgic, 2012, MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping, Neuroimage, 59, 2625, 10.1016/j.neuroimage.2011.08.077 Jenkinson, 2003, Fast, automated, N-dimensional phase-unwrapping algorithm, Magn Reson Med, 49, 193, 10.1002/mrm.10354 Smith, 2002, Fast robust automated brain extraction, Hum Brain Mapp, 17, 143, 10.1002/hbm.10062 Haacke, 2010, Susceptibility mapping as a means to visualize veins and quantify oxygen saturation, J Magn Reson Imaging, 32, 663, 10.1002/jmri.22276 Deistung, 2013, Toward in vivo histology: a comparison of quantitative susceptibility mapping (QSM) imaging at ultra high magnetic field strength with magnitude, phase, and R2*, Neuroimage, 65, 299, 10.1016/j.neuroimage.2012.09.055 Hallgren, 1958, The effect of age on the non-haemin iron in the human brain, J Neurochem, 3, 41, 10.1111/j.1471-4159.1958.tb12607.x Fawcett, 2006, An introduction to ROC analysis, Pattern Recognit Lett, 27, 861, 10.1016/j.patrec.2005.10.010 Ordidge, 1994, Assessment of relative brain iron concentrations using T2-weighted and T2*-weighted MRI at 3 Tesla, Magn Reson Med, 32, 335, 10.1002/mrm.1910320309 Gelman, 1999, MR imaging of human brain at 3.0T: preliminary report on transverse relaxation rates and relation to estimated iron content, Neuroradiology, 210, 759 Yao, 2009, Neuro image susceptibility contrast in high field MRI of human brain as a function of tissue iron content, Neuroimage, 44, 1259, 10.1016/j.neuroimage.2008.10.029 Hoehn, 1967, Parkinsonism: onset, progression and mortality, Neurology, 17, 427, 10.1212/WNL.17.5.427